Research and Development Korona Laboratory

Research and Development Korona Laboratory is a Russian biotechnology company focused on the development of innovative antiviral and anti-inflammatory therapeutics. The company gained prominence for its research into peptide-based treatments and small molecule inhibitors targeting respiratory viral infections, including COVID-19. Their work primarily involves the modulation of the immune response and the prevention of viral entry into host cells. Korona Laboratory operates as a specialized R&D entity, often collaborating with state institutions and larger pharmaceutical manufacturers in the Eurasian region to advance its pipeline through clinical trials.